| Peer reviewer | Employment | Honoraria/Speaking/Consulting | Speakers' bureau | Researcha | Fellowship supporta | Ownership/Partnership/Principal/Majority stockholder | Stock or stock options | Intellectual property/Royalties | Other |
|---|---|---|---|---|---|---|---|---|---|
| Samuel J. Asirvatham, MD, FHRS | Mayo Clinic College of Medicine, Rochester, Minnesota | 1: Abbott; 1: BIOTRONIK; 1: Boston Scientific; 1: Medtronic | None | None | None | None | None | 1: AliveCor | None |
| Eduardo Back Sternick, MD, PhD | Faculdade Ciências Médicas de Minas, Gerais, Brazil | None | None | None | None | None | None | None | None |
| Janice Chyou, MD | Northport VA Medical Center, Northport, New York; Agile Health, New York, New York | None | None | None | None | None | None | None | None |
| Sabine Ernst, MD, PhD | Royal Brompton and Harefield Hospitals, London, England | 2: Biosense Webster; 2: Stereotaxis | None | 3: Other; 4: Baylis; 4: Spectrum Dynamics | None | None | None | None | None |
| Guilherme Fenelon, MD, PhD | Hospital Israelita Albert Einstein, Sao Paulo, Sao Paulo, Brazil | 1: Libbs | None | None | None | None | None | None | None |
| Edward P. Gerstenfeld, MD, MS, FACC | University of California, San Francisco, San Francisco, California | 1: Abbott Vascular; 1: Biosense Webster; 1: Boston Scientific; 1: Medtronic | None | 4: Abbott Vascular; 4: Biosense Webster | None | None | None | None | None |
| Gerhard Hindricks, MD | Heart Center Leipzig at the University of Leipzig, Leipzig, Germany | None | None | 4: Abbott Vascular | None | None | None | None | None |
| Koichi Inoue, MD, PhD | Sakurabashi‐Watanabe Hospital, Osaka, Japan | 2: Biosense Webster; 2: Medtronic Japan | None | None | None | None | None | None | None |
| Jeffrey J. Kim, MD | Baylor College of Medicine, Texas Children's Hospital, Houston, Texas | None | None | None | 3: Medtronic | None | None | None | None |
| Kousik Krishnan, MD, FHRS, FACC | Rush University Medical Center, Chicago, Illinois | 1: ZOLL | None | None | None | None | None | None | None |
| Karl‐Heinz Kuck, MD, FHRS | Asklepios Klinik St. Georg, Hamburg, Germany | 1: Abbott Vascular; 1: Biosense Webster; 1: Boston Scientific; 1: Edwards Lifesciences; 1: Medtronic | None | None | None | None | None | None | None |
| Martin Ortiz Avalos, MD | Hospital San Angel Inn Universidad, Mexico City, Mexico | None | None | None | None | None | None | None | None |
| Thomas Paul, MD, FACC, FHRS | Georg August University Medical Center, Gottingen, Germany | None | None | None | None | None | None | None | None |
| Mauricio I. Scanavacca, MD, PhD | Instituto Do Coracao, Sao Paulo, Brazil | None | None | None | None | None | None | None | None |
| Roderick Tung, MD, FHRS | The University of Chicago Medicine, Center for Arrhythmia Care, Heart and Vascular Center, Chicago, Illinois | 2: Abbott | None | 2: Abbott | 3: Abbott; 3: Medtronic; 3: Boston Scientific | None | None | None | None |
| Jamie Voss, MBChB | Middlemore Hospital, Auckland, New Zealand | None | None | None | None | None | None | None | None |
| Takumi Yamada, MD | University of Alabama at Birmingham, Birmingham, Alabama | 1: Nihon Kohden; 2: Abbott; 2: Japan Lifeline | None | None | None | No; ne | None | None | None |
| Teiichi Yamane, MD, PhD, FHRS | Jikei University School of Medicine, Tokyo, Japan | 1: Boehringer Ingelheim; 1: Bristol‐Myers Squibb; 2: Abbott Laboratories; 2: Medtronic Japan | None | None | None | None | None | None | None |
Number value: 0 = $0; 1 = ≤$10 000; 2 = >$10 000 to ≤$25 000; 3 = >$25 000 to ≤$50 000; 4 = >$50 000 to ≤$100 000; 5 = >$100 000.
a
Research and fellowship support are classed as programmatic support. Sources of programmatic support are disclosed but are not regarded as a relevant relationship with industry for writing group members or reviewers.